Research Areas

A Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of An Investigational Medication, Ezetimibe and the Combination in Hypercholesterolemia Patients With or Without Statin Intolerance

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Trial of An Approved Medication as Adjunctive Therapy in Pediatric and Adult Subjects with Primary Generalized Tonic-Clonic Seizures

A Multicenter, Double Blind, Randomized, Placebo-Controlled Trial to Determine the Efficacy and Safety of An Investigational Medication as Adjunctive Therapy for Adults with Drug-Resistant Partial-Onset Seizures Followed by Long-term Open-Label Treatment

Clinical Evaluation of An Investigational Continuous Glucose Monitoring System (CM)

A Four-Week, Double-Blind, Placebo-Controlled Exploratory Evaluation of FEV Changes and Safety of an Investigational Medication in Patients with Chronic Obstructive Pulmonary Disease (COPD)

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Six Week Study of Efficacy and Safety of an investigational medication for Inhalation in Adults with Chronic Obstructive Pulmonary Disease

A Randomized, Multicenter, Double Blind, Double Dummy, Parallel Group Study to Evaluate the Efficacy and Safety of An Investigational Combination Inhalation Powder Compared With Fluticasone Propionate/Salmeterol Over 12 Weeks in Subjects with COPD

A Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of An Investigational Medication Versus Ezetimibe in High Cardiovascular Risk Patients with Hypercholesterolemia Not Adequately Controlled with their Statin Therapy

Clinical Evaluation of A Blood Glucose Monitor. (study discontinued early by the sponsor)

A Randomized, Double Blinded, Negative and Positive Controlled Study for Evaluation of the Allergenicity of A Marketed Medication in Healthy Volunteers Using Intradermal Skin Test

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of investigational medication to Patients with Type 2 Diabetes with Inadequate Glycemic Control on Metformin and Sulfonylurea Therapy in Combination with Simvastatin.

A Double-Blind, Randomized, Active-Controlled Investigational Medication and Metformin Comparator Study in Type 2 Diabetic Patients Inadequately Controlled on Diet and Exercise

A Multicenter, Double-Blind, Randomized, Active-Controlled Parallel Study in Patients With Type 2 Diabetes to Evaluate the Cardiac and Metabolic Effects of an Investigational Medication

An Open-Label Study of the Long Term Safety of an Investigational Medication Use in Patients with Type 1 or 2 Diabetes Mellitus

The Efficacy and Safety of an Investigational Medication for the Treatment of Type 2 Diabetes

Effect of an Investigational Medication Compared with Insulin Glargine in Patients with Type 2 Diabetes Also Using Combination Therapy with Sulfonylurea and Metformin.

Investigational Medication Titrate-To-Target: An observational study of the efficacy of an investigational medication in patients with Type 2 Diabetes Mellitus not achieving glycemic targets on OADs with/ without once daily basal insulin therapy.

A One-Year, Open, Randomized, Parallel, Three-Arm Study Comparing an investigational medication vs. Avandia (rosiglitazone maleate) as Add-On Therapy vs. an investigational medication Substitution of Sulfonylurea in Patients with Type 2 Diabetes, Poorly Controlled on Combination Sulfonylurea and Metformin Treatment.

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of an investigational medication Added to Insulin in Patients With Inadequately Controlled Type 2 Diabetes Mellitus

A Randomized, Multicenter, Double-Blind, Parallel Group, Placebo-Controlled Trial of an investigational medication for Glycemic Control in Patients With Diabetes Mellitus Type 2 With and Without Metformin